Showing results (21-30 of 544) with videos related to
Sort By:
Pageof 55
Biochimica Et Biophysica Acta|December 11, 1975
ATPase complex and oxidative phosphorylation in chloramphenicol-induced megamitochondria from mouse liverT Wagner, J RafaelEuropean Journal of Clinical Pharmacology|January 1, 1984
Bioavailability of cyclophosphamide from oral formulationsT Wagner, K FennebergEuropean Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 13, 2005
Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulationsH Kranz, T WagnerCancer Chemotherapy and Pharmacology|January 1, 1993
Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapyV Kurowski, T WagnerActa Physiologica Hungarica|January 1, 1988
Cysteamine protects against diarrhoea induced by castor oil. This protective effect can be potentiated by SH-alkylator treatmentE Ezer, T WagnerGeburtshilfe Und Frauenheilkunde|October 1, 1975
[A case of amniotic fluid embolism (author's transl)]J Kunz, T WagnerSchweizerische Medizinische Wochenschrift|January 3, 1976
[Aneurysm of the arteria lusoria. Report on 4 cases]T Wagner, S ThiryEuropean Journal of Biochemistry|January 1, 1980
The complex formation between Escherichia coli aminoacyl-tRNA, elongation factor Tu and GTP. The effect of the side-chain of the amino acid linked to tRNAT Wagner, M SprinzlCancer Chemotherapy and Pharmacology|January 1, 1997
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapyV Kurowski, T WagnerArzneimittel-Forschung|May 1, 1986
Pharmacokinetics and bioavailability of oral ifosfamideT Wagner, P DringsPageof 55